These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7784331)

  • 21. In vivo 'enkephalinase' inhibition by acetorphan in human plasma and CSF.
    Spillantini MG; Geppetti P; Fanciullacci M; Michelacci S; Lecomte JM; Sicuteri F
    Eur J Pharmacol; 1986 Jun; 125(1):147-50. PubMed ID: 3015640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naloxone-reversible antidiarrheal effects of enkephalinase inhibitors.
    Marçais-Collado H; Uchida G; Costentin J; Schwartz JC; Lecomte JM
    Eur J Pharmacol; 1987 Dec; 144(2):125-32. PubMed ID: 3481337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Action of enkephalinase (EC 3.4.24.11) inhibition on the pre- and post-prandial electromyographic patterns of colon in rats.
    Benouali S; Berard H; Roche M
    Neuropeptides; 1993 May; 24(5):299-305. PubMed ID: 8392143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Action of acetorphan, an enkephalinase inhibitor, in acute diarrhea].
    Baumer P; Danquechin Dorval E; Bertrand J; Vetel JM; Schwartz JC; Lecomte JM
    Ann Gastroenterol Hepatol (Paris); 1992; 28(6-7):279-85. PubMed ID: 1285638
    [No Abstract]   [Full Text] [Related]  

  • 25. [Anti-arrhythmia effects of enkephalinase inhibitors].
    Lishmanov IuB; Maslov LN; Uskina EV
    Eksp Klin Farmakol; 2001; 64(5):28-30. PubMed ID: 11764494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of endogenous enkephalins in locomotion evidenced by acetorphan, an "enkephalinase" inhibitor.
    Michael-Titus A; Preterre P; Giros B; Costentin J
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1062-6. PubMed ID: 3121843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New carboxyalkyl inhibitors of brain enkephalinase: synthesis, biological activity, and analgesic properties.
    Fournié-Zaluski MC; Chaillet P; Soroca-Lucas E; Marçais-Collado H; Costentin J; Roques BP
    J Med Chem; 1983 Jan; 26(1):60-5. PubMed ID: 6298420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Penicillins exhibit enkephalinase inhibitory activity in mice.
    Livingston SJ; Williams PS; Sewell RD; Smith HJ
    Prog Clin Biol Res; 1990; 328():413-6. PubMed ID: 2304960
    [No Abstract]   [Full Text] [Related]  

  • 29. Inactivation of atrial natriuretic factor in mice in vivo: crucial role of enkephalinase (EC 3.4.24.11).
    Gros C; Souque A; Schwartz JC
    Eur J Pharmacol; 1990 Apr; 179(1-2):45-56. PubMed ID: 2142086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Racecadotril demonstrates intestinal antisecretory activity in vivo.
    Primi MP; Bueno L; Baumer P; Berard H; Lecomte JM
    Aliment Pharmacol Ther; 1999 Dec; 13 Suppl 6():3-7. PubMed ID: 10646045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diuretic and natriuretic responses in rats treated with enkephalinase inhibitors.
    Bralet J; Mossiat C; Lecomte JM; Charpentier S; Gros C; Schwartz JC
    Eur J Pharmacol; 1990 Apr; 179(1-2):57-64. PubMed ID: 2142087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enkephalinase inhibitors. 1. 2,4-Dibenzylglutaric acid derivatives.
    Ksander GM; Diefenbacher CG; Yuan AM; Clark F; Sakane Y; Ghai RD
    J Med Chem; 1989 Dec; 32(12):2519-26. PubMed ID: 2585440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan.
    Gros C; Souque A; Schwartz JC; Duchier J; Cournot A; Baumer P; Lecomte JM
    Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7580-4. PubMed ID: 2529543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the abuse potential of acetorphan, an enkephalinase inhibitor.
    Knisely JS; Beardsley PM; Aceto MD; Balster RL; Harris LS
    Drug Alcohol Depend; 1989 Apr; 23(2):143-51. PubMed ID: 2702924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo.
    Mendelsohn LG; Johnson BG; Scott WL; Frederickson RC
    J Pharmacol Exp Ther; 1985 Aug; 234(2):386-90. PubMed ID: 3894620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects.
    Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM
    J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The enkephalinase inhibitor, acetorphan, in acute diarrhoea. A double-blind, controlled clinical trial versus loperamide.
    Roge J; Baumer P; Berard H; Schwartz JC; Lecomte JM
    Scand J Gastroenterol; 1993 Apr; 28(4):352-4. PubMed ID: 8488368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetorphan, an enkephalinase inhibitor, decreases gastric secretion in cats.
    Bado A; Chicau-Chovet M; Appia F; Dubrasquet M; Lecomte JM; Rozé C
    Peptides; 1987; 8(1):89-93. PubMed ID: 3554169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats.
    Noble F; Soleilhac JM; Soroca-Lucas E; Turcaud S; Fournie-Zaluski MC; Roques BP
    J Pharmacol Exp Ther; 1992 Apr; 261(1):181-90. PubMed ID: 1560364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New orally active enkephalinase inhibitors: their synthesis, biological activity, and analgesic properties.
    Senokuchi K; Nakai H; Nagao Y; Sakai Y; Katsube N; Kawamura M
    Bioorg Med Chem; 1998 Apr; 6(4):441-63. PubMed ID: 9597188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.